As a new form of the viral disease spreads through Central Africa, prompting a global emergency declaration, Stanford Medicine infectious disease specialist Abraar Karan discusses how health systems can prepare and respond.
Gianna Nino-Tapias knows the challenges of migrant farmworkers better than most. Her mother continues to pick blueberries daily. She plans to use her medical degree to help integrate and advocate for better health care.
What does it mean that H5N1 bird flu, also known as highly pathogenic avian influenza A, is spreading among dairy cows? And how should U.S. health systems — and consumers of milk products — be responding?
Researchers who study long COVID say its debilitating symptoms are often misdiagnosed by clinicians and dismissed by employers or loved ones because so little is known about the new syndrome.
Nationwide, the percentage of health care visits for flulike symptoms ticked up above the baseline at the start of November and has remained elevated ever since, according to the Centers for Disease Control and Prevention.
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
Stanford Medicine researchers are designing vaccines that might protect people from not merely individual viral strains but broad ranges of them. The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
Clinical fellow Alex Zimmet, MD, a member of Stanford Medicine’s antimicrobial stewardship team, discusses why antibiotic overuse is a problem and how you can help combat it.
Post-Nobel Prize announcement, we're spotlighting the science behind the mRNA-based COVID-19 vaccine and how it may impact medicine broadly.
Stanford Medicine infectious disease expert Anne Liu provides guidance on the RSV, flu and new COVID-19 vaccines this fall.
Scientists explain a key difference between the spike-protein molecules generated by the SARS-CoV-2 mRNA vaccine and those the virus induces.
Researchers at Stanford Medicine have shown that, globally, the rate of tuberculosis in prisons also drives tuberculosis in the community.
Stanford Medicine scientist Desiree LaBeaud partnered with artist Jean Shin to create art of our discarded plastic.
Stanford Medicine experts discuss the past successes and future potential of mRNA as a new type of medicine or treatment.
New CDC recommendation for universal hepatitis B screening could significantly reduce liver cancer in Asians and Black people, researchers say.
